Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 120

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1
Chunk 120
---
akis also received RSUs valued at $50,000 for his ongoing service as a Board member pursuant to our Director Compensation Policy. As of March 31, 2024, Mr. Gikakis had 4,885 shares of common stock subject to outstanding RSUs.

    (4)
    In the fiscal year ended March 31, 2025, Ms. Rossetti earned $63,000 for her roles as a director, a member of our Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee and as the chair of our Nominating and Corporate Governance Committee. Ms. Rossetti also received RSUs valued at $50,000 for her ongoing service as a Board member pursuant to our Director Compensation Policy. As of March 31, 2025, Ms. Rossetti had no outstanding equity awards.

    (5)
    Dr. Shah served as a member of our Audit Committee until September 15, 2023. In the fiscal year ended March 31, 2025, Dr. Shah earned $63,750 for his roles as a director, a member of our Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee and as the chair of our Compensation Committee. Dr. Shah also received RSUs valued at $50,000 for his ongoing service as a Board member pursuant to our Director Compensation Policy. 

Non-Employee Director Compensation Policy

We maintain the Director Compensation
Policy, in which only non-employee directors may participate, pursuant to which such non-employee directors are entitled to receive cash
and equity compensation for their service on the Board of Directors and its committees. Under the Director Compensation Policy in effect
during the fiscal year ended March 31, 2025, a newly appointed or elected eligible director will receive an initial grant of RSUs with
a grant date fair value of $75,000 or, at the discretion of our Board of Directors, options to acquire shares of common stock with a grant
date fair value of $75,000, based on the average of the closing prices of our common stock for the five trading day period ending on the
date of grant and will vest at a rate determined by the Board of Directors in its discretion, typically in equal quarterly installments
over one year.

In addition, under the Director
Compensation Policy, at the beginning of each fiscal year, each continuing director eligible to participate will receive a grant of RSUs
with a grant date fair value of $50,000 or,